News and Announcements
Mobilicom’s commercial drone upgrade solution receives order exceeding $280K from Israel Navy
- Published May 30, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Mobilicom is delighted to announce the receipt of over $280, 000 from the Israel Navy for its Commercial Drone Upgrade Solution.
- This takes the investment from the Israel Ministry of Defense for the Commercial Drone Upgrade Solution to over $850,000.
- Mobilicom is well on track to achieve its target of $1 million from the Israel Ministry of Defence by the end of 2019.
Mobilicom is delighted to announce the receipt of over $280, 000 from the Israel Navy for its Commercial Drone Upgrade Solution. This takes the investment from the Israel Ministry of Defence for the Commercial Drone Upgrade Solution to over $850,000.
The upgraded, after-market add on drone solution came about after the US ban on particular drones as a result of backdoor cyber risks. Recent sales have shown the high level of interest across numerous Ministry of Defence Units. The Israel Navy is an excellent demonstration and testament to the application of the product within the market.
Mobilicom is well on track to achieve its target of $1 million from the Israel Ministry of Defence by the end 2019.
Mobilicom (ASX: MOB)
Mobilicom designs, develops and markets solutions for mission-critical and remote mobile private communication networks without the need for, or use of, any existing infrastructure. Mobilicom’s products and technology merge 4G communication with Mobile MESH technologies into a unified solution, with several product families that have been commercially deployed. Mobilicom’s SkyHopper entity targets the Professional, Commercial and Industrial UAV market.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
